title: Second MRSA antibiotic reaches the market.
authors.forename: Jeffrey L
authors.initials: JL
authors.lastname: Fox
mesh_terms: D000900:Anti-Bacterial Agents; D017277:Drug Approval; D006020:Glycopeptides; D006801:Humans; D000077427:Lipoglycopeptides; D055624:Methicillin-Resistant Staphylococcus aureus; D013203:Staphylococcal Infections / Q000188:drug therapy*; D014640:Vancomycin / Q000031:analogs & derivatives
chemical_list: D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D000077427:Lipoglycopeptides; C100708:oritavancin; D014640:Vancomycin